Clinical implications of switching from intensive to moderate statin therapy after acute coronary syndromes

International Journal of Cardiology

Volumn 152, Issue 1, 2011, Pages 56-60

  Colivicchi, Furio ^a   Tubaro, Marco ^a   Santini, Massimo ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Acute coronary syndrome; Atorvastatin; Switching

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; PRAVASTATIN; SIMVASTATIN;

ACUTE CORONARY SYNDROME; AGED; AGING; ARTICLE; COHORT ANALYSIS; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPEPSIA; ENZYME BLOOD LEVEL; FATIGUE; FEMALE; FOLLOW UP; HEART REHABILITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYALGIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROBABILITY; SEX DIFFERENCE; SIDE EFFECT; TREATMENT RESPONSE;

ACUTE CORONARY SYNDROME; AGED; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; PROPORTIONAL HAZARDS MODELS; PYRROLES; RISK FACTORS;

EID: 80053566155     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.07.006     Document Type: Article

References (22)

1. J. Afilalo, A.A. Majdan, and M.J. Eisenberg Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials Heart 93 2007 914 921 (Pubitemid 47122038)
2. C.P. Cannon, B.A. Steinberg, S.A. Murphy, J.L. Mega, and E. Braunwald Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy J Am Coll Cardiol 48 2006 438 445 (Pubitemid 44109954)
3. D.D. Waters Safety of high-dose atorvastatin therapy Am J Cardiol 96 suppl 2005 69F 75F (Pubitemid 41207736)
4. D. Atar, R. Carmena, and P. Clemmensen Clinical review: impact of statin substitution policies on patient outcomes Ann Med 41 2009 242 256
5. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: 2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) Circulation 106 14 2002 1893 1900 [Available at: http://circ.ahajournals.org/cgi/content/full/ 106/14/1893 ]
6. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the ACC/AHA Task Force on Practice Guidelines Circulation 110 5 2004 588 636 [Available at: www.acc.org/qualityandscience/clinical/ guidelines/stemi/index.pdf ]
7. C.P. Cannon, C.H. McCabe, and R.G. Wilcox Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial Circulation 102 2000 149 156 (Pubitemid 30451770)
8. K. Eagle, E. Kline Rogers, and S.G. Goodman Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study Am J Med 117 2004 73 81 (Pubitemid 38953725)
9. P.M. Ho, J.A. Spertus, and F.A. Masoudi Impact of medication therapy discontinuation on mortality after myocardial infarction Arch Intern Med 166 2006 1842 1847 (Pubitemid 44455166)
10. F. Colivicchi, A. Bassi, M. Santini, and C. Caltagirone Discontinuation of statin therapy and clinical outcome after ischemic stroke Stroke 38 2007 2652 2657 (Pubitemid 47493999)
11. A.J. Greenspon, R.G. Hart, and D. Dawson Predictors of stroke in patients paced for sick sinus syndrome JACC 43 2004 1617 1622 (Pubitemid 38561343)
12. B.B. Granger, K. Swedberg, and I. Ekman Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: doubleblind, randomised, controlled clinical trial Lancet 366 2005 2005 2011 (Pubitemid 41773375)
13. E. Lesaffre, D. Kocmanova, P. Lemos, C. Disco, and P.W. Serruys A retrospective analysis of the effect of non-compliance on time to first major adverse cardiac event in LIPS Clin Ther 25 2003 2431 2447 (Pubitemid 37267250)
14. F. Boutitie, F. Gueyeffier, S.J. Pocock, and J.P. Boissel Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials Stat Med 17 1998 2883 2903 (Pubitemid 28562982)
15. N.F. Schlecht, R.W. Platt, and A. Negassa Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions Am J Epid 158 2003 878 886 (Pubitemid 37323250)
16. M. Thomas, and J. Mann Increased thrombotic vascular events after change of statin Lancet 352 1998 1830 1831 (Pubitemid 28550081)
17. B. Phillips, C. Roberts, A.E. Rudolph, S. Morant, F. Aziz, and C.P. O'Regan Switching statins: the impact on patient outcomes Br J Cardiol 14 2007 280 285 (Pubitemid 350226458)
18. R. Butler, and J. Wainwright Cholesterol lowering in patients with CHD and metabolic syndrome [letter] Lancet 369 2007 27 (Pubitemid 46027223)
19. H.D. Aronow, G. Hess, J. Hill, A. Kuznik, and L.Z. Liu Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol Am J Ther 17 2010 167 175 [Electronic publication ahead of print]
20. K.K. Ray, and C.P. Cannon Early time to benefit with intensive statin treatment: could it be the pleiotropic effects? Am J Cardiol 96 suppl 2005 54F 60F (Pubitemid 41207734)
21. K.K. Ray, C.P. Cannon, and C.H. McCabe Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial J Am Coll Cardiol 46 2005 1405 1410 (Pubitemid 41446173)
22. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150